Latest Whitepapers

This whitepaper explores how transitioning from RUO to cGMP chemicals can mitigate risks, streamline processes and maintain regulatory compliance, ultimately accelerating your journey from lab to clinic.

This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.

This article explores major advances in disease modification for illnesses that still lack effective treatments, as well as some challenges and approaches to overcome them.

This whitepaper explores the latest advancements in OOC platforms that can help to efficiently simulate drug toxicity responses.

This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.

Cell therapies, from regenerative medicine to immunotherapy, are transforming the medical landscape with 75 already approved globally and over 2,000 in development.

This article explores new workflows using data-driven modeling to improve culture medium and new control algorithms allowing for better modulation within the bioprocess design space.

In this article, Mark Lawler, professor of digital health, answers your questions about these revolutionary techniques and discusses the barriers to their implementation in the clinic. Prof. Lawler has an international reputation in cancer research and a focus on developing a molecular understanding of cancer to improve patient care, including through precision medicine.

This article explores how quality control can improve protocol standardization, enhance scalability and ensure that cultures meet regulatory criteria.

The sensitivity and specificity of mass spectrometry (MS) has made it an indispensable tool for biopharmaceutical analysis, ensuring the safety and efficacy of biologics.